Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
- Status
- COMPLETED
- Phase
- PHASE2
VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
- Status
- COMPLETED
- Phase
- PHASE2
Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
- Status
- COMPLETED
- Phase
- PHASE2